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Figure 1. Key steps in the apoptotic signaling pathways.  
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The Bcl-2 family of proteins Apoptosis 
Apoptosis is an extremely regulated cell death program which is essential 
during development and for the maintenance of cell turnover in adult 
tissues. The study of this process is currently of great interest in biomedical 
science as it is involved in neoplastic events and viral infections as well as in 
neurodegenerative and cardiovascular diseases.  
Control of apoptosis by Bcl-2 family members 
Conclusions 
Suitability of the yeast as a model for apoptosis: 
 It has an apoptotic machinery similar to that present in mammals.  
 It is a low-complexity model that allows study of individual interactions between the molecules involved in this pathway. 
 It is useful for screening inhibitors of anti-apoptotic proteins.  
 It is suitable for testing new drugs prior to its use in mammalian cell lines.  
It lacks the anti and pro-apoptotic molecules observed in mammals.  
The results cannot be extrapolated to a multicellular organism and they must be validated in animal models.  
Recent and major improvements in mammalian cell culture media leave this model aside. 
 
Applications and perspectives: 
Many diseases are linked to apoptotic processes. Understanding how the process is regulated in a simple 
model like the one herein presented might help develop effective therapies against these pathologies. 
S.cerevisiae is a useful tool for studying the mechanism of action of the Bcl-2 family of proteins and for the 
comprehension of its function in the cell. It can also be used for the identification of new therapeutic targets 
and for activity and specificity evaluation of different drugs. 
Evidences of two different models of activation 1 Bcl-2 proteins interact via their BH3 domain 2 
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Figure 5. Mechanisms of Bax and Bak activation and Bcl-2 sensitization triggered 
by BH3-only proteins. [3] 
 BH3-only proteins could activate Bax in the cytosol or at the 
MOM.  
 With activation of the intrinsic pathway, the mitochondrial 
membrane loses its integrity and permeabilizes. Some evidences 
suggests that this is due to pore formation in the MOM. 
 
 Different models describing this process have been proposed: 
 Formation of proteinaceous channels.  
 Lipidic pore formation induced by Bax and Bak. 
 Pore formation influenced by Bax, Bak and mitochondrial 
membrane lipids. 
 Increase in permeability of an existing channel induced by Bax 
and Bak. 
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 It is an eukaryotic system 
 Several genes involved in human disease have 
yeast orthologs. 
 Many biochemical mechanisms are conserved 
from yeast to human. 
 Allows easy genetic manipulation 
 Applications as an experimental tool include: 
• Protein-fragment complementation assays 
• Drug-screening assays 
• Functional assays by heterologous expression 
of human proteins (humanized yeast) 
Yeast as a model organism 
Mutants in CDC48p show typical 
markers of apoptosis. This is the first 
indication of the apoptotic process in 
yeast.  
Deletion of the ASF1/CIA histone 
chaperone in yeast leads to cellular cycle 
arrest at G2/M stage and cellular death 
with apoptotic traits. HtrA/Omi y AIF, two of the proteins that leave 
mitochondrion after the apoptotic signal, have yeast 
homologs: Nma111p and Aif1p. 
The expression of human disease 
associated proteins and pro-
apoptotic proteins such as Bax 
and Bak, triggers apoptosis in 
yeast. 
A yeast protein named Ybh3p harbours a 
BH3 domain  similar to the pro-apoptotic 
proteins found in mammals.   
Caspase activity: S.cerevisiae 
has a metacaspase (YCA1). 
Saccharomyces  
cerevisiae 
Saccharomyces cerevisiae triggers an apoptotic phenotype 
 This complex activates pro-caspase 9 
which in turn activates effector 
caspases.  
 
 Bcl-2 pro-apoptotic members activation 
leads to Mitochondrial Outer 
Membrane permeabilization (MOMP). 
Figure 3. Structure of Bax. 1F16 PDB. [1]  
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Direct Model 
 BH3-only proteins induce a conformational 
change in Bax leading to its insertion into the 
MOM. 
 The interaction with BH3-only proteins 
activates Bax and Bak, leading to the formation 
of higher order oligomers. 
Indirect Model 
 BH3-only proteins bind to Bcl-2 anti-apoptotic 
proteins and prevent their binding to Bax and 
Bak, triggering apoptosis. 
Growth viability assays in yeast reveal that 
BH3-only proteins are unable to directly 
potentiate the activation of effector pro-
apoptotic proteins.  
In vitro mitochondrial import assays suggest integral 
membrane insertion of these proteins by its C-
terminal end.  
Apoptosis and therapeutic agents 
 BH3 mimetic inhibitors like ATB-737 or ABT-263, which 
antagonize the anti-apoptotic proteins, exhibit a great potential 
for cancer therapy.  
 Like BH3-only proteins, these peptides bind to the anti-
apoptotic proteins and prevent apoptosis inhibition. 
Figure 6. Impact of different drugs on yeast expressing Bax with Bcl-2 anti-apoptotic members. E1B19K, 
DPV022 and SPPV14 are viral Bcl-2 proteins.  This graph displays the absorbance of each drug-treated culture 
when the corresponding untreated culture was closest to 0.5. DMSO (black), ABT-737 (red), ABT-263 
(orange), TW-37 (violet), HA14-1 (green) and Obatoclax (blue). [4]  
 S.cerevisiae can also be used to identify: 
• Caspase activators 
• IAP antagonists (anti-inhibitors of apoptosis) 
Figure 2. Homology domains of Bcl-2 family of proteins. 
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 The members of the Bcl-2 family are the main regulators of the intrinsic pathway of cell 
death. 
 
 These proteins control the efflux of cytochrome c and other intermembrane proteins 
from mitochondrion to the cytosol where the first one associates to Apaf1 and to pro-
caspase 9 to form the apoptosome complex.  
Pro-apoptotic effector proteins 
 • Bak is inserted in the MOM. 
• Bax is translocated to the mitochondrion 
after the apoptotic signal. 
Pro-apoptotic BH3-only proteins 
Bid, Bad, Bik, Bim, Puma and Noxa are proteins 
constituted by a unique BH3 domain.  
Its role in the cell can be explained by two 
different models :  
 
• Direct model: Bax and Bak are activated by 
BH3-only proteins. 
 
• Indirect model: Pro-survival proteins are 
inhibited by BH3-only proteins. 
Pro-survival proteins 
Bcl-2, Bcl-X, Bcl-W, Mcl-1 and A1 are 
anti-apoptotic proteins. They avoid 
formation of the pore by association 
with Bax or Bak. 
Bax and Bak both oligomerize and lead to the 
formation of a pore in the MOM through 
which cytochrome c is released. 
 
Figure 4. The BH3 domain of Bax is essential for its interaction with the anti-apoptotic 
proteins. Yeast are co-transformed with the corresponding Bcl-2 prosurvival protein and 
Bax or mutant Bax D68R under an inducible GAL promoter. ON (in the presence of 
galactose), OFF (in the presence of glucose). [2] 
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